These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25326399)

  • 21. Median nerve motor conduction velocity is concordant with myelin protein zero gene mutation.
    Lee YC; Soong BW; Liu YT; Lin KP; Kao KP; Wu ZA
    J Neurol; 2005 Feb; 252(2):151-5. PubMed ID: 15729519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expansion of the phenotypic spectrum of X-linked Charcot-Marie-Tooth (CMT) disease.
    Yang Q; Xiao X; Yuan Z; Jiao B; Liao X; Du J
    J Clin Neurosci; 2020 Mar; 73():311-313. PubMed ID: 31987637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GDAP1 mutations in Italian axonal Charcot-Marie-Tooth patients: Phenotypic features and clinical course.
    Pezzini I; Geroldi A; Capponi S; Gulli R; Schenone A; Grandis M; Doria-Lamba L; La Piana C; Cremonte M; Pisciotta C; Nolano M; Manganelli F; Santoro L; Mandich P; Bellone E
    Neuromuscul Disord; 2016 Jan; 26(1):26-32. PubMed ID: 26525999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New novel mutations in Brazilian families with X-linked Charcot-Marie-Tooth disease.
    Gouvea SP; Tomaselli PJ; Barretto LS; Perina KCB; Nyshyama FS; Nicolau N; Lourenço CM; Marques W
    J Peripher Nerv Syst; 2019 Jun; 24(2):207-212. PubMed ID: 31119804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The frequency of 17p11.2 duplication and Connexin 32 mutations in 282 Charcot-Marie-Tooth families in relation to the mode of inheritance and motor nerve conduction velocity.
    Dubourg O; Tardieu S; Birouk N; Gouider R; Léger JM; Maisonobe T; Brice A; Bouche P; LeGuern E
    Neuromuscul Disord; 2001 Jul; 11(5):458-63. PubMed ID: 11404117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotype of Charcot-Marie-Tooth disease Type 2.
    Bienfait HM; Baas F; Koelman JH; de Haan RJ; van Engelen BG; Gabreëls-Festen AA; Ongerboer de Visser BW; Meggouh F; Weterman MA; De Jonghe P; Timmerman V; de Visser M
    Neurology; 2007 May; 68(20):1658-67. PubMed ID: 17502546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Six novel connexin32 (GJB1) mutations in X-linked Charcot-Marie-Tooth disease.
    Lee MJ; Nelson I; Houlden H; Sweeney MG; Hilton-Jones D; Blake J; Wood NW; Reilly MM
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):304-6. PubMed ID: 12185164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel GARS mutation presenting as autosomal dominant intermediate Charcot-Marie-Tooth disease.
    Nan H; Takaki R; Hata T; Ichinose Y; Tsuchiya M; Koh K; Takiyama Y
    J Peripher Nerv Syst; 2019 Mar; 24(1):156-160. PubMed ID: 30394614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutation screening of Cx32 in Han Chinese patients with Charcot-Marie-Tooth disease.
    Zhang RX; Luo W; Zi XH; Xia K; Cai F; Xiao JF; Zhao GH; Zhang FF; Shen L; Jiang H; Tang BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Feb; 37(1):68-71. PubMed ID: 15719046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-linked Charcot-Marie-Tooth disease caused by a novel point mutation in the connexin-32 gene.
    Ma W; Farrukh Nizam M; Grewal RP
    Neurol Sci; 2002 Oct; 23(4):195-7. PubMed ID: 12536289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease.
    Barbat du Closel L; Bonello-Palot N; Péréon Y; Echaniz-Laguna A; Camdessanche JP; Nadaj-Pakleza A; Chanson JB; Frachet S; Magy L; Cassereau J; Cintas P; Choumert A; Devic P; Leonard Louis S; Gravier Dumonceau R; Delmont E; Salort-Campana E; Bouhour F; Latour P; Stojkovic T; Attarian S
    Eur J Neurol; 2023 Oct; 30(10):3265-3276. PubMed ID: 37335503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Charcot-Marie-Tooth: From Molecules to Therapy.
    Morena J; Gupta A; Hoyle JC
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic epidemiology of Charcot-Marie-Tooth in the general population.
    Braathen GJ; Sand JC; Lobato A; Høyer H; Russell MB
    Eur J Neurol; 2011 Jan; 18(1):39-48. PubMed ID: 20482598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mosaicism for GJB1 mutation causes milder Charcot-Marie-Tooth X1 phenotype in a heterozygous man than in a manifesting heterozygous woman.
    Borgulová I; Mazanec R; Sakmaryová I; Havlová M; Safka Brožková D; Seeman P
    Neurogenetics; 2013 Nov; 14(3-4):189-95. PubMed ID: 23912496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The spectrum of Charcot-Marie-Tooth disease due to myelin protein zero: An electrodiagnostic, nerve ultrasound and histological study.
    Fabrizi GM; Tamburin S; Cavallaro T; Cabrini I; Ferrarini M; Taioli F; Magrinelli F; Zanette G
    Clin Neurophysiol; 2018 Jan; 129(1):21-32. PubMed ID: 29136549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked Charcot-Marie-Tooth disease: molecular analysis of interfamilial variability.
    Niewiadomski LA; Kelly TE
    Am J Med Genet; 1996 Dec; 66(2):175-8. PubMed ID: 8958325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characterization and genetic analysis of Korean patients with X-linked Charcot-Marie-Tooth disease type 1.
    Hong YB; Park JM; Yu JS; Yoo DH; Nam DE; Park HJ; Lee JS; Hwang SH; Chung KW; Choi BO
    J Peripher Nerv Syst; 2017 Sep; 22(3):172-181. PubMed ID: 28448691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients.
    Choi BO; Lee MS; Shin SH; Hwang JH; Choi KG; Kim WK; Sunwoo IN; Kim NK; Chung KW
    Hum Mutat; 2004 Aug; 24(2):185-6. PubMed ID: 15241803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Review of X-linked Charcot-Marie-Tooth Disease.
    Wang Y; Yin F
    J Child Neurol; 2016 May; 31(6):761-72. PubMed ID: 26385972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular diagnosis and clinical onset of Charcot-Marie-Tooth disease in Japan.
    Abe A; Numakura C; Kijima K; Hayashi M; Hashimoto T; Hayasaka K
    J Hum Genet; 2011 May; 56(5):364-8. PubMed ID: 21326314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.